Literature DB >> 14704032

Molecular pharmacodynamics in childhood leukemia.

R Pieters1, M L den Boer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14704032     DOI: 10.1007/bf02983812

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  184 in total

1.  In vitro glucocorticoid resistance in childhood leukemia correlates with receptor affinity determined at 37 degrees C, but not with affinity determined at room temperature.

Authors:  E G Haarman; G J L Kaspers; R Pieters; M M A Rottier; M L Den Boer; G E Janka-Schaub; A J P Veerman
Journal:  Leukemia       Date:  2002-09       Impact factor: 11.528

2.  A mechanism of resistance to 6-mercaptopurine: metabolism of hypoxanthine and 6-mercaptopurine by sensitive and resistant neoplasms.

Authors:  R W BROCKMAN
Journal:  Cancer Res       Date:  1960-06       Impact factor: 12.701

3.  DNA binding of the glucocorticoid receptor is not essential for survival.

Authors:  H M Reichardt; K H Kaestner; J Tuckermann; O Kretz; O Wessely; R Bock; P Gass; W Schmid; P Herrlich; P Angel; G Schütz
Journal:  Cell       Date:  1998-05-15       Impact factor: 41.582

4.  Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia.

Authors:  A Argiris; G S Longo; R Gorlick; W Tong; P Steinherz; J R Bertino
Journal:  Leukemia       Date:  1997-06       Impact factor: 11.528

5.  Alternatively spliced glucocorticoid receptor messenger RNAs in glucocorticoid-resistant human multiple myeloma cells.

Authors:  P A Moalli; S Pillay; N L Krett; S T Rosen
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

6.  In vitro drug resistance profile of Philadelphia positive acute lymphoblastic leukemia is heterogeneous and related to age: a report of the Dutch and German Leukemia Study Groups.

Authors:  N L Ramakers-van Woerden; R Pieters; D Hoelzer; R M Slater; M L den Boer; A H Loonen; J Harbott; G E Janka-Schaub; W-D Ludwig; G J Ossenkoppele; E R van Wering; A J P Veerman
Journal:  Med Pediatr Oncol       Date:  2002-06

7.  Resistance to 1-beta-D-arabinofuranosylcytosine in human T-lymphoblasts mediated by mutations within the deoxycytidine kinase gene.

Authors:  J K Owens; D S Shewach; B Ullman; B S Mitchell
Journal:  Cancer Res       Date:  1992-05-01       Impact factor: 12.701

8.  Polymorphism of the thymidylate synthase gene and outcome of acute lymphoblastic leukaemia.

Authors:  M Krajinovic; I Costea; S Chiasson
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

9.  Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.

Authors:  B Y Bugg; M K Danks; W T Beck; D P Suttle
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

10.  Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemia.

Authors:  J S Lilleyman; L Lennard
Journal:  Lancet       Date:  1994-05-14       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.